These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 1828371
21. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Pannell R, Gurewich V. Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889 [Abstract] [Full Text] [Related]
22. Regulated localization confers multiple functions on the protease urokinase plasminogen activator. Wells JM, Strickland S. J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470 [Abstract] [Full Text] [Related]
24. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study. Ellis V, Scully MF, Kakkar VV. J Biol Chem; 1987 Nov 05; 262(31):14998-5003. PubMed ID: 3667621 [Abstract] [Full Text] [Related]
25. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system. Aisina RB, Mukhametova LI, Gulin DA, Levashov MY, Prisyazhnaya NV, Gershkovich KB, Varfolomeyev SD. Biochemistry (Mosc); 2009 Oct 05; 74(10):1104-13. PubMed ID: 19916923 [Abstract] [Full Text] [Related]
26. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK. Liu JN, Gurewich V. Biochemistry; 1992 Jul 14; 31(27):6311-7. PubMed ID: 1385727 [Abstract] [Full Text] [Related]
27. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase. Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D. Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361 [Abstract] [Full Text] [Related]
28. Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin. Husain SS. J Biol Chem; 1993 Apr 25; 268(12):8574-9. PubMed ID: 8473303 [Abstract] [Full Text] [Related]
29. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice. List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Danø K, Behrendt N. Biochemistry; 2000 Jan 25; 39(3):508-15. PubMed ID: 10642175 [Abstract] [Full Text] [Related]
30. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu). Lijnen HR, Van Hoef B, Nelles L, Collen D. J Biol Chem; 1990 Mar 25; 265(9):5232-6. PubMed ID: 1969415 [Abstract] [Full Text] [Related]
31. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ, Lee SW, Dichek DA, Ellis V. J Pept Sci; 2000 Sep 25; 6(9):432-9. PubMed ID: 11016879 [Abstract] [Full Text] [Related]
32. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding. Jiao J, Yu M, Ru B. Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444 [Abstract] [Full Text] [Related]
33. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation. Behrendt N, List K, Andreasen PA, Danø K. Biochem J; 2003 Apr 15; 371(Pt 2):277-87. PubMed ID: 12534347 [Abstract] [Full Text] [Related]
34. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1. Orgel D, Schröder W, Hecker-Kia A, Weithmann KU, Kolkenbrock H, Ulbrich N. Clin Chem Lab Med; 1998 Sep 15; 36(9):697-702. PubMed ID: 9804393 [Abstract] [Full Text] [Related]
35. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Lijnen HR, Wnendt S, Schneider J, Janocha E, Van Hoef B, Collen D, Steffens GJ. Eur J Biochem; 1995 Nov 15; 234(1):350-7. PubMed ID: 8529664 [Abstract] [Full Text] [Related]
36. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor. Niedbala MJ, Bajetta S, Carbone R, Sartorelli AC. Cancer Commun; 1990 Nov 15; 2(9):317-24. PubMed ID: 2169831 [Abstract] [Full Text] [Related]
37. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator. Li XK, Lijnen HR, Nelles L, Hu MH, Collen D. Biochim Biophys Acta; 1992 Sep 04; 1159(1):37-43. PubMed ID: 1390910 [Abstract] [Full Text] [Related]
38. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. Estreicher A, Mühlhauser J, Carpentier JL, Orci L, Vassalli JD. J Cell Biol; 1990 Aug 04; 111(2):783-92. PubMed ID: 2166055 [Abstract] [Full Text] [Related]
39. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. Petersen LC, Lund LR, Nielsen LS, Danø K, Skriver L. J Biol Chem; 1988 Aug 15; 263(23):11189-95. PubMed ID: 2969891 [Abstract] [Full Text] [Related]
40. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA). Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D. Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]